CLINICAL-FEATURES OF MULTIPLE ENDOCRINE NEOPLASIA TYPE-1 AND TYPE-2

被引:19
|
作者
RAUE, F
ZINK, A
机构
关键词
WERMER SYNDROME; SIPPLE SYNDROME; MEN-1; MEN-2A; MEN-2B; PARATHYROID TUMOR; PANCREATIC ISLET CELL TUMOR; PITUITARY TUMOR; MEDULLARY THYROID CARCINOMA; PHEOCHROMOCYTOMA; SCREENING;
D O I
10.1159/000182589
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The term 'Multiple Endocrine Neoplasia' (MEN) denotes a genetically determined syndrome characterized by the independent appearance of benign or malignant changes of several endocrine organs as well as occasional changes of neural, muscular and connective tissue. Three different forms have been identified: MEN 1 (Wermer's syndrome) includes parathyroid hyperplasia in combination with pancreatic islet cell and pituitary tumours; MEN 2a (Sipple's syndrome) includes medullary thyroid carcinoma in association with phaeochromocytoma and parathyroid hyperplasia; MEN 2b includes medullary thyroid carcinoma, phaeochromocytoma and mucosal neuromas. MEN syndrome is transmitted as an autosomal dominant trait with a high degree of penetrance. The changes in the individual glands appear to be causally and temporally independent of each other. A spectrum of pathological changes exist in the affected glands which range from hyperplasia to adenoma to carcinoma. The pathological process is almost always multicentric, often resulting in bilateral disease of organs. The appearance of an endocrine tumour known to be associated with MEN should alert the physician to the possibility of a MEN syndrome. When the possibility of such a syndrome exists, screening and long-term observation should be initiated to diagnose a carcinoma in its earliest stage, or before the development of clinical manifestations of hormone excess.
引用
收藏
页码:31 / 35
页数:5
相关论文
共 50 条
  • [1] MULTIPLE ENDOCRINE NEOPLASIA TYPE-1 - CLINICAL-FEATURES AND SCREENING
    SKOGSEID, B
    RASTAD, J
    OBERG, K
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1994, 23 (01) : 1 - 18
  • [2] MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 - CLINICAL-FEATURES AND SCREENING
    RAUE, F
    FRANKRAUE, K
    GRAUER, A
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1994, 23 (01) : 137 - 156
  • [3] CLINICAL AND GENETIC FEATURES OF ADRENOCORTICAL LESIONS IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-1
    SKOGSEID, B
    LARSSON, C
    LINDGREN, PG
    KVANTA, E
    RASTAD, J
    THEODORSSON, E
    WIDE, L
    WILANDER, E
    OBERG, K
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (01): : 76 - 81
  • [4] SURGICAL-MANAGEMENT OF PRIMARY HYPERPARATHYROIDISM IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-1 AND TYPE-2
    ORIORDAIN, DS
    OBRIEN, T
    GRANT, CS
    WEAVER, A
    GHARIB, H
    VANHEERDEN, JA
    ALLO, M
    PATWARDHAN, NA
    CLARK, OH
    NORTON, JA
    SANDELIN, K
    TALPOS, GB
    THOMPSON, NW
    SURGERY, 1993, 114 (06) : 1031 - 1039
  • [5] MULTIPLE ENDOCRINE NEOPLASIA TYPE-1
    YAMAGUCHI, K
    KAMEYA, T
    ABE, K
    CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1980, 9 (02): : 261 - 284
  • [6] Multiple endocrine neoplasia type-2
    Conte-Devolx, B
    Niccoli-Sire, P
    ANNALES D ENDOCRINOLOGIE, 2003, 64 (05) : 389 - 392
  • [7] MULTIPLE ENDOCRINE NEOPLASIA TYPE-2
    FORSTERGIBSON, CJ
    MULLIGAN, LM
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (13) : 1969 - 1974
  • [8] MULTIPLE ENDOCRINE NEOPLASIA TYPE-2
    SIZEMORE, GW
    HEATH, H
    CARNEY, JA
    CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1980, 9 (02): : 299 - 315
  • [9] MULTIPLE ENDOCRINE NEOPLASIA TYPE-2
    WELLS, SA
    ONTJES, DA
    ANNUAL REVIEW OF MEDICINE, 1976, 27 : 263 - 268
  • [10] GENETIC AND CLINICAL CHARACTERISTICS OF MULTIPLE ENDOCRINE NEOPLASIA TYPE-1
    SKOGSEID, B
    LARSSON, C
    OBERG, K
    ACTA ONCOLOGICA, 1991, 30 (04) : 485 - 488